Facebook
Twitter
LinkedIn
ForwardClick here to search courses using NAPNAP's previous Course Catalog layout.
Title
Category
Credits
Event date
Cost
- Acute Care
- Pharmacology CE
- 1.50 Contact hours
$30.00
1.5 NAPNAP Contact Hour, 0.5 Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $15 for NAPNAP Members. For non- members, this continuing education activity rate is $30.
Jennifer Joiner is a dual certified pediatric nurse practitioner who serves as the inpatient nurse practitioner for The Children’s Heart Center at the Children’s Hospital of San Antonio for Baylor College of Medicine. Jen has had the privilege of taking care of almost every population of patient in critical care and has been a preceptor and lead of several advanced practice groups. She served as an original test item writer for the PNCB's pilot exam in Acute Care in 2004 and assisted the PNCB by writing acute care pediatric updates for many years.
- Mental Health
- Pharmacology CE
- Psychopharmacology CE
- 1.75 Contact hours
$35.00
1.75 NAPNAP contact hour, of which 1.75 is Pharmacology and 1.75 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $17.5 for NAPNAP Members. For non- members, this continuing education activity rate is $35.
This presentation reviews the neurological/biological basis and treatment of psychiatric conditions common to children and adolescents. The presenters will cover the basic anatomy and physiology of the brain to guide a neurological review of common pediatric psychiatric conditions. This knowledge is then used to discuss the pharmacological treatment of psychiatric conditions in the clinical setting.
- Mental Health
- Pharmacology CE
- Psychopharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP contact hour, of which 1.0 is Pharmacology and 1.0 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20.
An extensive review will provide the participant with up-to-date information about commonly used antidepressants and atypical antipsychotics.
- Mental Health
- Pharmacology CE
- Psychopharmacology CE
- 0.75 Contact hours
$15.00
0.75 NAPNAP contact hour, of which0.5 is Pharmacology, 0.5 Psychopharmacology and 0.25 is Controlled substance. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $7.5 for NAPNAP Members. For non- members, this continuing education activity rate is $15.
The purpose of this session is to provide the pediatric-focused APRN with an introduction to the use and effects of cannabis on children and youth. The discussion includes a conversation about the current cannabis laws, the physiologic effects of cannabis, the evidence for cannabis use in pediatrics and guideline for facilitating discussions with families who have interest in using cannabis for their children. This session is appropriate for providers from all patient care settings and for the novice to seasoned APRN.
- Mental Health
- Pharmacology CE
- Psychopharmacology CE
- 1.25 Contact hours
$25.00
1.25 NAPNAP contact hour, of which 0.5 is Pharmacology and 0.5 Psychopharmacology. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.5 for NAPNAP Members. For non- members, this continuing education activity rate is $25.
This session will focus on the increased prevalence of anxiety and depression in children and adolescents in our post-COVID society. The lack of available child psychology and psychiatry services has increased the role of pediatric-focused NPs in providing evidence-based treatment of young patients with these diagnoses throughout the pandemic. Using case-based scenarios and interactive technology, participants will discuss factors impacting symptom presentation and review pharmacologic and non-pharmacologic treatment strategies. Innovative, COVID-friendly mental health resources and coping strategies for children, adolescents and their families will be presented.
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour of which 0.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. The presenters will address four chronic health conditions that can present challenges to the pediatric-focused NP in a primary care clinic: congenital heart disease, chronic renal failure, post traumatic brain injury and cystic fibrosis. Clinical experts will present the primary care needs of children with medical complexity, which may be different from other children coming to your clinic, including vaccination schedules, medications, developmental considerations and when to call the specialist.
- Primary Care
- Pharmacology CE
- 1.00 Contact hours
$20.00
1.0 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. This presentation will cover the latest research, new medications and updated practice guidelines in pediatric migraine management as well as how to evaluate and use the current evidence in practice.
- Primary Care
- FREE for Members
- Pharmacology CE
- 1.00 Contact hours
$10.00
1.0 NAPNAP contact hour, 1.0 pharmacology contact hour. This continuing education activity is offered free to NAPNAP Members. For non-members, this continuing education activity rate is $10. Before 2018, there were no U.S. Food and Drug Administration approved medications for managing seizures in Dravet syndrome (DS). Common agents used in the antiepileptic drug regimens of patients with DS included clobazam, valproic acid, topiramate, and levetiracetam, among others; however, these agents alone rarely provide adequate seizure control. Management of seizures in DS changed in recent years with the approval of cannabidiol and stiripentol in 2018 and fenfluramine in 2020. This continuing education article summarizes available efficacy and safety data involving cannabidiol, stiripentol, and fenfluramine and provides a practical review of dosing strategies, pharmacokinetics, and monitoring interventions relevant to their use. J Pediatr Health Care. (2022)
36, 479−488
- Primary Care
- Infectious Disease
- Pharmacology CE
- 1.25 Contact hours
$25.00
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is an archived presentation from NAPNAP's 2023 National Conference.
Antibiotics are the most commonly prescribed medications in pediatrics. This presentation will review current antibiotic resistance patterns and provide a rapid-fire review of current guidelines for prescribing antibiotics for pediatric patients.
- Primary Care
- FREE for Members
- Immunization
- Pharmacology CE
- 1.25 Contact hours
$12.50
1.25 NAPNAP Contact Hour of which 1.25 contain pharmacology content. This continuing education activity is free for NAPNAP Members. For non-members, this continuing education activity rate is $12.50. This course is an archived presentation from NAPNAP's 2023 National Conference and is offered free with a coupon for conference attendees until 12/31/23.
While presenting the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines.
Educational support for this course was provided by Sanofi.